[1]于海洋,秦忠,李文,等.金水宝胶囊治疗新型冠状病毒肺炎后遗症的临床应用价值[J].西部中医药,2022,35(04):1-4.[doi:10.12174/j.issn.2096-9600.2022.04.01]
 YU Haiyang,QIN Zhong,LI Wen,et al.Clinical Application Value of Jinshuibao Capsules in the Treatment of Sequelae of COVID-19[J].Western Journal of Traditional Chinese Medicine,2022,35(04):1-4.[doi:10.12174/j.issn.2096-9600.2022.04.01]
点击复制

金水宝胶囊治疗新型冠状病毒肺炎后遗症的临床应用价值
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年04期
页码:
1-4
栏目:
新冠肺炎
出版日期:
2022-04-15

文章信息/Info

Title:
Clinical Application Value of Jinshuibao Capsules in the Treatment of Sequelae of COVID-19
作者:
于海洋 秦忠 李文 刘怀全 陈云志
贵州中医药大学,贵州 贵阳 550025
Author(s):
YU Haiyang QIN Zhong LI Wen LIU Huaiquan CHEN Yunzhi
Guizhou University of Chinese Medicine, Guiyang 550025, China
关键词:
新型冠状病毒肺炎后遗症金水宝胶囊中医药
Keywords:
COVID-19sequelaecapsuleTCM
分类号:
R563.1
DOI:
10.12174/j.issn.2096-9600.2022.04.01
文献标志码:
A
摘要:
金水宝胶囊可通过多靶点、多环节、多途径的形式协助机体改善新型冠状病毒肺炎后遗症状。通过分析相关文献,从抗炎、抗氧化、抑制破骨细胞活性、调节体内激素水平、改善肠道菌群等方面就其作用机制进行阐述,旨在指导临床治疗。
Abstract:
Jinshuibao capsule has been widely used in clinical study and basic experiment, it may help the body to improve sequelae of COVID-19 possibly through many targets, links and approaches, and to mitigate clinical symptoms by anti-inflammation, anti-oxidation, inhibiting the activity of osteoclast, regulating hormone levels in vivo and improving intestinal flora. In-vivo mechanism of Jinshuibao capsules in the treatment of COVID-19 at the recovery stage is analyzed, in order to guide clinical treatment.

相似文献/References:

[1]李赟,王彩弟,王建云,等.简约远程中医诊疗在新型冠状病毒肺炎隔离病区中的应用[J].西部中医药,2020,33(S1):1.
 LI Yun,WANG Caidi,WANG Jianyun,et al.The Application of Simple Remote TCM Diagnosis and Treatment to COVID-19 Quarantined Inpatient Area[J].Western Journal of Traditional Chinese Medicine,2020,33(04):1.
[2]宋忠阳,雍文兴,张利英,等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验*[J].西部中医药,2020,33(S1):3.
 SONG Zhongyang,YONG Wenxing,ZHANG Liying,et al.The Experience of TCM Clinical Characteristics, Syndrome Differentiation and Treatment for COVID-19 in Gansu Province[J].Western Journal of Traditional Chinese Medicine,2020,33(04):3.
[3]杜洪霖,马战平△.西北地区新型冠状病毒肺炎的中医特点及防治*[J].西部中医药,2020,33(S1):5.
 DU Honglin,MA Zhanping.TCM Characteristics, the Prevention and Treatment of COVID-19 in Northwest China[J].Western Journal of Traditional Chinese Medicine,2020,33(04):5.
[4]潘文,李盛华,王晓萍,等.中医对新型冠状病毒肺炎的认识与防治探讨[J].西部中医药,2020,33(S1):7.
 PAN Wen,LI Shenghua,WANG Xiaoping,et al.On TCM Understanding, the Prevention and Treatment of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(04):7.
[5]杨海侠,张银萍△,杨长虹,等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J].西部中医药,2020,33(S1):13.
[6]丁潇,邹忆怀△,辛大永,等.北京顺义地区新型冠状病毒肺炎的中医临床证候与CT表现[J].西部中医药,2020,33(S1):16.
 DING Xiao,ZOU Yihuai,XIN Dayong,et al.TCM Clinical Syndromes and CT Manifestations of COVID-19 in Shunyi District of Beijing[J].Western Journal of Traditional Chinese Medicine,2020,33(04):16.
[7]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
 SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(04):18.
[8]闫向勇,李 俊,燕忠生△.武汉地区新型冠状病毒肺炎中医证候及病机特点[J].西部中医药,2020,33(S1):20.
 YAN Xiangyong,LI Jun,YAN Zhongsheng.On the Characteristics of TCM Patterns and the Pathogenesis of COVID-19 in Wuhan Region[J].Western Journal of Traditional Chinese Medicine,2020,33(04):20.
[9]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用*[J].西部中医药,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
 and Treatment of COVID-9 in Zhongshan Region.The Application of Lingnan Genuine Drugs to the Prevention[J].Western Journal of Traditional Chinese Medicine,2020,33(04):24.[doi:10.1056/NEJMoa-2001017]
[10]朱玉,黎玉婷,姚德蛟△.从中西医不同角度分析麻杏石甘汤治疗新型冠状病毒肺炎的作用[J].西部中医药,2020,33(S1):26.
 of Traditional Chinese Medicine and Western Medicine.The Functions of Maxing Shigan Tang in the Treatment for COVID-19 from the Angles[J].Western Journal of Traditional Chinese Medicine,2020,33(04):26.

备注/Memo

备注/Memo:
于海洋(1996—),男,在读硕士研究生。研究方向:中医证候物质基础。国家自然科学基金项目(81460694);贵州省教育厅项目(黔教合KY字〔2017〕172,〔2017〕041);第四批全国中医(临床、基础)优秀人才研修项目(国中医药人教发〔2017〕24号)。
更新日期/Last Update: 2022-06-24